These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 11401423
1. Time-dependent influence of pentoxifylline on the pharmacokinetics of orally administered carbamazepine in human subjects. Poondru S, Devaraj R, Boinpally RR, Yamsani MR. Pharmacol Res; 2001 Mar; 43(3):301-5. PubMed ID: 11401423 [Abstract] [Full Text] [Related]
2. Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits. García AL, Medina RL, Pérez MR, Jung CH. Biopharm Drug Dispos; 2003 Jul; 24(5):205-9. PubMed ID: 12784320 [Abstract] [Full Text] [Related]
3. Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults. Chien S, Bialer M, Solanki B, Verhaeghe T, Doose DR, Novak G, Yao C. Epilepsia; 2006 Nov; 47(11):1830-40. PubMed ID: 17116022 [Abstract] [Full Text] [Related]
7. Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers. Shahzadi A, Javed I, Aslam B, Muhammad F, Asi MR, Ashraf MY, Zia-ur-Rahman. Pak J Pharm Sci; 2011 Jan; 24(1):63-8. PubMed ID: 21190921 [Abstract] [Full Text] [Related]
9. Effects of sinapic acid on hepatic cytochrome P450 3A2, 2C11, and intestinal P-glycoprotein on the pharmacokinetics of oral carbamazepine in rats: Potential food/herb-drug interaction. Raish M, Ahmad A, Ansari MA, Alkharfy KM, Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Khan A, Ali N. Epilepsy Res; 2019 Jul; 153():14-18. PubMed ID: 30927680 [Abstract] [Full Text] [Related]
10. Effects of artemisinin, artemether, arteether on the pharmacokinetics of carbamazepine. Sukhija M, Medhi B, Pandhi P. Pharmacology; 2006 Jul; 76(3):110-6. PubMed ID: 16388199 [Abstract] [Full Text] [Related]
11. A single and multiple dose bioavailability study with carbamazepine 400 mg retard tablets with reference to enzyme autoinduction and circadian time differences. Hoffmann C, Zschiesche M, Franke G, Hoffmann A, Terhaag B, Möritz KU, Siegmund W. Int J Clin Pharmacol Ther; 1997 Nov; 35(11):496-503. PubMed ID: 9401830 [Abstract] [Full Text] [Related]
12. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine. Britzi M, Perucca E, Soback S, Levy RH, Fattore C, Crema F, Gatti G, Doose DR, Maryanoff BE, Bialer M. Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535 [Abstract] [Full Text] [Related]
13. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models. Fortuna A, Alves G, Soares-da-Silva P, Falcão A. Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973 [Abstract] [Full Text] [Related]
14. Effect of lamotrigine on the pharmacokinetics of carbamazepine and its active metabolite in dogs. Matar KM, Nicholls PJ, Bawazir SA, Al-Khamis KI, Al-Hassan MI. Eur J Drug Metab Pharmacokinet; 2001 Nov; 26(3):149-53. PubMed ID: 11695714 [Abstract] [Full Text] [Related]
15. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. El Desoky ES, Sabarinath SN, Hamdi MM, Bewernitz M, Derendorf H. J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329 [Abstract] [Full Text] [Related]